Jefferies Lowers Price Target for IO Biotech Jefferies has maintained its “Buy” rating for IO Biotech (NASDAQ: IOBT) but has reduced its price target from...
Dyne Therapeutics Announces Key Leadership Changes Dyne Therapeutics (Nasdaq: DYN), a clinical-stage company specializing in muscle disease therapeutics, has unveiled significant leadership appointments to bolster...
Berkshire Hathaway’s Bank of America Stake Shrinks – Warren Buffett’s Berkshire Hathaway Inc. is getting close to a point where it won’t need to quickly...
Tesla’s China Sales Rise in August Despite Layoffs – Tesla’s sales of China-made electric vehicles (EVs) increased by 3% year-over-year in August. This data comes...